Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA CongressGlobeNewsWire • 05/14/25
Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025GlobeNewsWire • 05/09/25
Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025GlobeNewsWire • 05/02/25
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/01/25
Agios Reports First Quarter 2025 Financial Results and Recent Business HighlightsGlobeNewsWire • 05/01/25
Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/24/25
Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025GlobeNewsWire • 04/17/25
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy OfficerGlobeNewsWire • 03/05/25
Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025GlobeNewsWire • 02/20/25
Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 02/13/25
Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsGlobeNewsWire • 02/13/25
Agios' Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary EndpointGlobeNewsWire • 02/13/25
Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025GlobeNewsWire • 02/06/25
Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business OfficerBusiness Wire • 01/08/25
Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025GlobeNewsWire • 01/03/25
European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios' Mitapivat in Sickle Cell DiseaseGlobeNewsWire • 12/18/24
Agios Crashes 19% After A Surprise Side Effect Hammered Its 'Very Safe' DrugInvestors Business Daily • 12/09/24